Recorded fact · drug.label_indication
drug.label_indication for interferon-beta-1b|multiple-sclerosis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact aae7476e resolves to.
The record
| Fact id | aae7476e0dce06498abfb68e |
|---|---|
| Entity | drug: interferon-beta-1b|multiple-sclerosis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260303 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 58ae90d36f551e0c8ef4babf71b564cf4010d58a2064880108787feb8d144155.
The value
{
"ingredient": "Interferon Beta-1b",
"conditionId": "multiple-sclerosis",
"conditionName": "Multiple Sclerosis",
"matchedAlias": "multiple sclerosis",
"context": "indication",
"brand": "Betaseron",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "66311f74-0472-4fa3-848a-06002ca0def5",
"labelEffectiveTime": "20260303",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 41db386064f9c12cb4f2c323d2b63527d99797cc8e5366c23e96beb4971568f6.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.